sb 239063 has been researched along with mocetinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barone, FC; Christopher, TA; Gao, F; Lopez, BL; Ma, XL; Ohlstein, EH; Shi, DW; Yue, TL | 1 |
1 other study(ies) available for sb 239063 and mocetinostat
Article | Year |
---|---|
p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation.
Topics: Analysis of Variance; Animals; Endothelium, Vascular; Imidazoles; Intercellular Adhesion Molecule-1; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; P-Selectin; p38 Mitogen-Activated Protein Kinases; Peroxidase; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2002 |